A
lexandria Real Estate Equities, Inc. (NYSE:ARE) is a top pick among the 12 Best REIT Stocks to Buy Right Now, despite mixed analyst sentiment following its Q2 2025 earnings report. The company owns and develops lab and office campuses in innovation hubs like Boston, San Francisco, and New York, managing over 44 million square feet across 391 properties.
Alexandria Real Estate's client base consists of leading biotech and pharmaceutical tenants under long-term leases. In its Q2 2025 earnings report, the company announced a record-breaking lease of 466,000 square feet and reported FFO per share at $2.33 with 2.0% cash same-property NOI growth for the first half of 2025.
The company's occupancy rate stands at 90.8%, but analysts remain divided on the stock. Citi maintains a Hold rating, while Citizens JMP reiterates a Buy rating. RBC Capital lowered its price target from $100 to $98 while sticking to their Sector Perform rating.
Despite mixed analyst views, Alexandria Real Estate attracts strong institutional interest, with 40 hedge funds backing its specialized life science property portfolio and long-term lease structures. However, we believe certain AI stocks offer greater upside potential and carry less downside risk.
realestate
Alexandria REIT Secures Record Lease Amid Divided Analyst Sentiment
Alexandria Real Estate Equities (NYSE:ARE) is a top REIT stock to buy, with mixed analyst sentiment following strong Q2 2025 earnings.
Read More - realestate
realestate
Analyst's UDR Warning Signals Confidence in Real Estate Resilience
Late Nov 2025: Major firms cut UDR outlooks, lower expectations, and issue mixed future guidance.
Read More - realestate
realestate
Top Youngest, Wealthiest U.S. Suburbs Unveiled—5 Serve NYC Commuters
New study: Young, affluent professionals favor Northeast over Silicon Valley.
Read More
realestate
City Council Weighs Nonprofit Home Ownership Bill, Could Delay Closings
NYC Council weighs bill to expand nonprofits' access to residential and commercial real estate.